These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30277869)

  • 1. The role of inflammatory markers in assessment of disease activity in systemic sclerosis.
    Ross L; Stevens W; Rabusa C; Wilson M; Ferdowsi N; Walker J; Sahhar J; Ngian GS; Zochling J; Roddy J; Tymms K; Major G; Strickland G; Proudman SM; Nikpour M
    Clin Exp Rheumatol; 2018; 36 Suppl 113(4):126-134. PubMed ID: 30277869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group.
    Muangchan C; Harding S; Khimdas S; Bonner A; ; Baron M; Pope J
    Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1405-14. PubMed ID: 22556030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of simple hematological parameters with disease manifestations, activity, and severity in patients with systemic sclerosis.
    Yayla ME; İlgen U; Okatan İE; UsluYurteri E; Torgutalp M; Keleşoğlu Dinçer AB; Aydemir Gülöksüz EG; Sezer S; Turgay TM; Kınıklı G; Ateş A
    Clin Rheumatol; 2020 Jan; 39(1):77-83. PubMed ID: 31317426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline.
    Colaci M; Giuggioli D; Sebastiani M; Manfredi A; Lumetti F; Luppi F; Cerri S; Ferri C
    Reumatismo; 2015 Dec; 67(4):149-55. PubMed ID: 27215180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thresholds for the 28-joint disease activity score (DAS28) using C-reactive protein are lower compared to DAS28 using erythrocyte sedimentation rate in early rheumatoid arthritis.
    Kuriya B; Schieir O; Lin D; Xiong J; Pope J; Boire G; Haraoui B; Thorne JC; Tin D; Hitchon C; Jamal S; Keystone E; Bykerk VP;
    Clin Exp Rheumatol; 2017; 35(5):799-803. PubMed ID: 28339365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of low complement with disease activity in systemic sclerosis: a prospective cohort study.
    Esposito J; Brown Z; Stevens W; Sahhar J; Rabusa C; Zochling J; Roddy J; Walker J; Proudman SM; Nikpour M
    Arthritis Res Ther; 2016 Oct; 18(1):246. PubMed ID: 27770830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential biomarkers in patients with systemic sclerosis.
    Delle Sedie A; Riente L; Maggiorini L; Pratesi F; Tavoni A; Migliorini P; Puxeddu I
    Int J Rheum Dis; 2018 Jan; 21(1):261-265. PubMed ID: 29024388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory stays inflammatory: a subgroup of systemic sclerosis characterized by high morbidity and inflammatory resistance to cyclophosphamide.
    Mitev A; Christ L; Feldmann D; Binder M; Möller K; Kanne AM; Hügle T; Villiger PM; Voll RE; Finzel S; Kollert F
    Arthritis Res Ther; 2019 Dec; 21(1):262. PubMed ID: 31791379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcopenia in systemic sclerosis: the impact of nutritional, clinical, and laboratory features.
    Corallo C; Fioravanti A; Tenti S; Pecetti G; Nuti R; Giordano N
    Rheumatol Int; 2019 Oct; 39(10):1767-1775. PubMed ID: 31372720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiopoietins-1 and -2 are differentially expressed in the sera of patients with systemic sclerosis: high angiopoietin-2 levels are associated with greater severity and higher activity of the disease.
    Michalska-Jakubus M; Kowal-Bielecka O; Chodorowska G; Bielecki M; Krasowska D
    Rheumatology (Oxford); 2011 Apr; 50(4):746-55. PubMed ID: 21149250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Six-minute walk distance as a marker for disability and complaints in patients with systemic sclerosis.
    Deuschle K; Weinert K; Becker MO; Backhaus M; Huscher D; Riemekasten G
    Clin Exp Rheumatol; 2011; 29(2 Suppl 65):S53-9. PubMed ID: 21586219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can Patient-Reported Symptoms Be Used to Measure Disease Activity in Systemic Sclerosis?
    Ross L; Stevens W; Wilson M; Strickland G; Walker J; Sahhar J; Ngian GS; Roddy J; Major G; Proudman S; Baron M; Nikpour M
    Arthritis Care Res (Hoboken); 2020 Oct; 72(10):1459-1465. PubMed ID: 31421031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of vascular dysfunction markers reflect disease severity and stage in systemic sclerosis patients.
    Cossu M; Andracco R; Santaniello A; Marchini M; Severino A; Caronni M; Radstake T; Beretta L
    Rheumatology (Oxford); 2016 Jun; 55(6):1112-6. PubMed ID: 26989111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung disease.
    Moore OA; Proudman SM; Goh N; Corte TJ; Rouse H; Hennessy O; Morrisroe K; Thakkar V; Sahhar J; Roddy J; Youssef P; Gabbay E; Nash P; Zochling J; Stevens W; Nikpour M
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S111-6. PubMed ID: 26243401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do We Have Good Activity Indices in Systemic Sclerosis?
    Groseanu L; Petrescu S; Balanescu A; Bojinca V; Opris-Belinski D; Berghea F; Mazilu D; Saulescu I; Borangiu A; Daia-Iliescu S; Constantinescu C; Cobilinschi C; Abobului M; Negru MM; Ionescu R
    Curr Rheumatol Rev; 2022; 18(1):39-47. PubMed ID: 34517805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Joint and tendon involvement predict disease progression in systemic sclerosis: a EUSTAR prospective study.
    Avouac J; Walker UA; Hachulla E; Riemekasten G; Cuomo G; Carreira PE; Caramaschi P; Ananieva LP; Matucci-Cerinic M; Czirjak L; Denton C; Ladner UM; Allanore Y; ;
    Ann Rheum Dis; 2016 Jan; 75(1):103-9. PubMed ID: 25165035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian Scleroderma Research Group registry.
    Khimdas S; Harding S; Bonner A; Zummer B; Baron M; Pope J;
    Arthritis Care Res (Hoboken); 2011 Jan; 63(1):142-9. PubMed ID: 20740608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using the Juvenile Arthritis Disease Activity Score based on erythrocyte sedimentation rate or C-reactive protein level: results from the Portuguese register.
    Mourão AF; Santos MJ; Melo-Gomes J; Martins FM; Costa JA; Ramos F; Brito I; Duarte C; Figueira R; Figueiredo G; Furtado C; Lopes A; Oliveira M; Rodrigues A; Salgado M; Sousa M; Branco JC; Fonseca JE; Canhão H
    Arthritis Care Res (Hoboken); 2014 Apr; 66(4):585-91. PubMed ID: 25354266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with disease progression in early-diagnosed pulmonary arterial hypertension associated with systemic sclerosis: longitudinal data from the DETECT cohort.
    Mihai C; Antic M; Dobrota R; Bonderman D; Chadha-Boreham H; Coghlan JG; Denton CP; Doelberg M; Grünig E; Khanna D; McLaughlin VV; Müller-Ladner U; Pope JE; Rosenberg DM; Seibold JR; Vonk MC; Distler O
    Ann Rheum Dis; 2018 Jan; 77(1):128-132. PubMed ID: 29061853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of European Scleroderma Group Activity Index in an early scleroderma cohort.
    Nevskaya T; Baron M; Pope JE;
    Rheumatology (Oxford); 2017 Jul; 56(7):1111-1122. PubMed ID: 28340090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.